Myrio at AACR 2025

Myrio Showcases Innovative KRAS Immunotherapy Research at SITC Spring Edition, San Diego March 12-14th 2025
March 14, 2025
Myrio Tx publishes in Cancer Cell
June 6, 2025
Myrio Showcases Innovative KRAS Immunotherapy Research at SITC Spring Edition, San Diego March 12-14th 2025
March 14, 2025
Myrio Tx publishes in Cancer Cell
June 6, 2025

Related posts

October 30, 2025

Myrio Therapeutics, the University of Pennsylvania Perelman School of Medicine, and NYU Langone Health have entered a research collaboration to accelerate the development of next-generation T cell immunotherapies

Read more
June 17, 2025

U.S. Food & Drug Administration (FDA) Approves Investigational New Drug (IND) Application for Myrio’s Lead Product (PHOX2B PC-CAR T) for the Treatment of Neuroblastoma

Read more
June 6, 2025

Myrio Tx publishes in Cancer Cell

Read more